Search Results for keywords:"conflicts of interest"

The Federal Election Commission is holding a public meeting virtually on Thursday, January 14, 2021, at 10:00 a.m. due to the COVID-19 pandemic. Attendees can access the meeting through the FEC's website. The meeting will cover various topics, including draft advisory opinions and audit reports on several political entities. For more details, interested individuals can contact Judith Ingram, the Press Officer.

The Securities and Exchange Commission (SEC) is seeking public comments on the collection of information required by Rule 304 of Regulation ATS. This rule pertains to alternative trading systems and requires them to submit Form ATS-N, providing details about their operations to increase transparency and reduce conflicts of interest. The SEC estimates it takes about 1,901 hours a year for entities to comply with these requirements. Comments on the usefulness and burden of the information collection are invited until January 31, 2025.

The Securities and Exchange Commission (SEC) has issued a notice regarding an application from several investment companies, including Pearl Diver Credit Company Inc., seeking to engage in joint investments. These investments are typically prohibited under the Investment Company Act of 1940, but the applicants are requesting an order to allow these activities under certain conditions. A hearing on this application will only take place if requested, with a deadline for such requests set for February 17, 2025. Additional details, including how to request a hearing, are available on the SEC's website.

The National Cancer Institute has scheduled a closed meeting on December 10, 2024, to evaluate requests for resources for developing new cancer treatments. The meeting is closed to protect sensitive information such as trade secrets and personal data. Due to exceptional circumstances, like the unexpected volume of project requests, the notice for this meeting was issued less than 15 days in advance. Missing this meeting could cause significant delays in cancer research funding and clinical trials.

The Options Clearing Corporation (OCC) submitted a rule change to the Securities and Exchange Commission (SEC) to update its documentation on how it calculates margin requirements for its members. This new document, called the STANS Methodology Description, aims to improve transparency about OCC's risk-based margin system by replacing a previous document while excluding certain outdated or redundant details. The SEC approved the proposal, believing it aligns with existing laws and regulations, and helps OCC manage risk in the event that a member defaults, thereby protecting the funds and securities in its care.

The Center for Scientific Review announced several upcoming closed meetings to review and evaluate grant applications. These sessions will be held virtually at the National Institutes of Health from March 11 to March 19, 2021. The meetings are closed to the public to protect confidential information and personal privacy associated with the applications. Key areas of focus include medical imaging, neurosciences, cardiovascular devices, and more.

The Department of Defense's Office of the General Counsel is requesting public feedback on a proposed information collection related to conflicts of interest for members of certain defense advisory committees. This proposal, part of the compliance with the Paperwork Reduction Act, seeks comments on the necessity and practicality of the information being collected, and ways to improve it while minimizing the burden on respondents. The form, called SD Form 830, aims to identify potential conflicts of interest among committee members. The public has until February 10, 2025, to submit comments on the proposal.

The National Institutes of Health is announcing a closed meeting of the National Advisory Allergy and Infectious Diseases Council. The meeting, scheduled for April 24, 2025, will take place from 3:00 p.m. to 5:00 p.m. and will focus on reviewing and evaluating grant applications. It will be held at the National Institute of Allergy and Infectious Diseases in Rockville, MD, using video assistance. The meeting will be closed to the public to protect confidential information and personal privacy. Interested individuals can submit written comments to Dr. Kelly Y. Poe at least 10 days before the meeting.

The Securities and Exchange Commission has approved a rule change proposed by the Financial Industry Regulatory Authority (FINRA) to amend the rules about removing members from FINRA's National Adjudicatory Council (NAC). This change aligns the reasons for removing a NAC member with those for removing a governor from the FINRA Board, including removal "for any cause affecting the best interests" judged by the FINRA Board. This is intended to enhance governance and assure fair representation of FINRA members, supporting investor protection and public interest through fair and impartial adjudication processes. The decision emphasizes the importance of the NAC's independence, integrity, and freedom from conflicts of interest.